Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03841786 · ClinicalTrials.gov registry record · NA

Effect of Phosphorus Additives on the Metabolome in Healthy Adults

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03841786 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03841786, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This study evaluates the effect of phosphorus supplementation on the human metabolome. The investigators will do so by conducting a cross-over study in healthy adults consuming a study diet (normal diet supplemented by neutral sodium phosphorus, 1 gram/day) for seven days and a control diet (normal diet supplemented by sodium and potassium chloride only) for seven days with a 28 day wash-out period in between. Untargeted metabolomic analyses will be done in serum samples obtained at the end of each diet period.

Interventions

  • OTHER Control Diet
  • OTHER Phosphorus-supplemented study diet

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-06-28
Est. Completion 2022-09-15
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03841786

The ClinicalTrials.gov registry entry for NCT03841786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control Diet is the first listed.

NCT03841786 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03841786 about?

NCT03841786 is a clinical study titled "Effect of Phosphorus Additives on the Metabolome in Healthy Adults". This study evaluates the effect of phosphorus supplementation on the human metabolome. The investigators will do so by conducting a cross-over study in healthy adults consuming a study diet (normal diet supplemented by neutral sodium phosphorus, 1 gram/day) for seven days and a control diet (normal ...

What is the current status of trial NCT03841786?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-28. Estimated completion is 2022-09-15.

What interventions are being tested in trial NCT03841786?

The interventions under investigation include: Control Diet (OTHER), Phosphorus-supplemented study diet (OTHER).

Who is sponsoring clinical trial NCT03841786?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.